Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 6 studies | 34% ± 16% | |
endothelial cell | 5 studies | 23% ± 9% | |
classical monocyte | 4 studies | 22% ± 6% | |
conventional dendritic cell | 4 studies | 25% ± 8% | |
fibroblast | 4 studies | 22% ± 9% | |
plasmablast | 3 studies | 45% ± 19% | |
hematopoietic precursor cell | 3 studies | 22% ± 2% | |
non-classical monocyte | 3 studies | 31% ± 4% | |
myeloid cell | 3 studies | 22% ± 4% | |
ciliated cell | 3 studies | 26% ± 9% | |
erythroblast | 3 studies | 36% ± 21% | |
glutamatergic neuron | 3 studies | 20% ± 3% | |
dendritic cell | 3 studies | 31% ± 8% | |
goblet cell | 3 studies | 21% ± 6% | |
plasmacytoid dendritic cell | 3 studies | 22% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 3 studies | 20% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 100% | 2163.12 | 966 / 966 | 100% | 55.60 | 527 / 527 |
kidney | 100% | 3355.81 | 89 / 89 | 100% | 63.07 | 901 / 901 |
liver | 100% | 3899.35 | 226 / 226 | 100% | 59.47 | 406 / 406 |
pancreas | 100% | 1536.21 | 328 / 328 | 100% | 49.59 | 178 / 178 |
skin | 100% | 2581.17 | 1809 / 1809 | 100% | 68.83 | 472 / 472 |
brain | 100% | 1551.85 | 2638 / 2642 | 100% | 68.52 | 705 / 705 |
thymus | 100% | 2613.45 | 653 / 653 | 100% | 58.51 | 604 / 605 |
lung | 100% | 2507.31 | 578 / 578 | 100% | 54.50 | 1151 / 1155 |
stomach | 100% | 2604.57 | 359 / 359 | 100% | 48.37 | 285 / 286 |
uterus | 100% | 1242.89 | 170 / 170 | 100% | 63.98 | 457 / 459 |
breast | 100% | 2231.87 | 459 / 459 | 99% | 61.03 | 1110 / 1118 |
prostate | 100% | 2534.73 | 244 / 245 | 100% | 75.79 | 500 / 502 |
bladder | 100% | 1799.43 | 21 / 21 | 99% | 59.71 | 499 / 504 |
esophagus | 100% | 1587.96 | 1443 / 1445 | 99% | 32.60 | 181 / 183 |
ovary | 98% | 971.54 | 177 / 180 | 100% | 40.96 | 430 / 430 |
adrenal gland | 100% | 3632.73 | 258 / 258 | 98% | 35.71 | 226 / 230 |
adipose | 100% | 2157.42 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 85.15 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 76.29 | 29 / 29 |
spleen | 100% | 3000.08 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 62.22 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 30.45 | 1 / 1 |
peripheral blood | 99% | 1957.69 | 918 / 929 | 0% | 0 | 0 / 0 |
heart | 98% | 1253.13 | 847 / 861 | 0% | 0 | 0 / 0 |
muscle | 97% | 1044.21 | 778 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 96% | 918.25 | 1286 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006457 | Biological process | protein folding |
GO_0009312 | Biological process | oligosaccharide biosynthetic process |
GO_0006488 | Biological process | dolichol-linked oligosaccharide biosynthetic process |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005515 | Molecular function | protein binding |
Gene name | MPDU1 |
Protein name | Mannose-P-dolichol utilization defect 1, isoform CRA_a (cDNA FLJ57749, highly similar to Mannose-P-dolichol utilization defect 1 protein) Mannose-P-dolichol utilization defect 1 isoform 1 Mannose-P-dolichol utilization defect 1 protein (Suppressor of Lec15 and Lec35 glycosylation mutation homolog) (SL15) Mannose-P-dolichol utilization defect 1 protein Mannose-P-dolichol utilization defect 1 Mannose-P-dolichol utilization defect 1 isoform 4 Mannose-P-dolichol utilization defect 1, isoform CRA_c (cDNA FLJ57743, highly similar to Mannose-P-dolichol utilization defect 1 protein) |
Synonyms | hCG_42012 |
Description | FUNCTION: Required for normal utilization of mannose-dolichol phosphate (Dol-P-Man) in the synthesis of N-linked and O-linked oligosaccharides and GPI anchors. . FUNCTION: Required for normal utilization of mannose-dolichol phosphate (Dol-P-Man) in the synthesis of N-linked and O-linked oligosaccharides and GPI anchors. . FUNCTION: Required for normal utilization of mannose-dolichol phosphate (Dol-P-Man) in the synthesis of N-linked and O-linked oligosaccharides and GPI anchors. . |
Accessions | ENST00000423172.6 [O75352-2] A0A291FGE0 A0A291FGC8 ENST00000584378.5 ENST00000580834.5 I3L261 ENST00000584479.5 A0A0S2Z4W8 ENST00000574558.1 J3KTK8 J3QW43 ENST00000396501.8 ENST00000576272.5 J3QRD5 J3KT75 J3QQZ4 ENST00000572719.5 ENST00000572936.5 O75352 J3KSI4 I3L405 I3L4T1 I3L1D2 ENST00000582151.1 ENST00000579445.5 ENST00000359822.10 A0A0S2Z4T4 ENST00000581380.1 ENST00000576066.5 J3QS48 ENST00000570458.5 ENST00000250124.11 [O75352-1] ENST00000571822.5 I3L4E0 ENST00000585217.5 B4DMY7 ENST00000580708.5 I3L295 B4DLH7 |